Q3 FY2023 · Quarterly report
48 pages
Read MoonLake Immunotherapeutics's results firsthand
Preview the first 2 pages of this quarterly report
Create a free account to start reading
Full documents are included with Professional
MoonLake Immunotherapeutics
NNASDAQ:MLTX11.56
USD
-0.14
(-1.20%)
